{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:52:39Z","timestamp":1790481159142,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["OT27XQX48U"],"award-info":[{"award-number":["OT27XQX48U"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["OP20.05187 RI-SI-EATRIS"],"award-info":[{"award-number":["OP20.05187 RI-SI-EATRIS"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022863","name":"Statistical Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006021","name":"Direction G\u00e9n\u00e9rale de l\u2019Armement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005989","name":"Ministrstvo za Izobra\u017eevanje, Znanost in \u0160port","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cbi.2025.111830","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:30:14Z","timestamp":1763605814000},"page":"111830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and \u03b17 nicotinic receptor"],"prefix":"10.1016","volume":"423","author":[{"given":"Peter","family":"Mastnak-Sokolov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damijan","family":"Knez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u017ee","family":"Meden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nika","family":"Stra\u0161ek Benedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svit","family":"Ferjan\u010di\u010d Benetik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hrast Rambaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0161a","family":"Zorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Brazzolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Jardemark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Jungholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bruton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Strandback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-3083","authenticated-orcid":false,"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111830_bib1","series-title":"A Blueprint for Dementia Research","year":"2022"},{"issue":"10284","key":"10.1016\/j.cbi.2025.111830_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English Translation of Alzheimer's 1907 Paper, \u201c\u00dcber Eine Eigenartige Erkankung Der Hirnrinde.\u201d","volume":"8","author":"Stelzmann","year":"1995","journal-title":"Clin. Anat."},{"issue":"8004","key":"10.1016\/j.cbi.2025.111830_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(77)91780-9","article-title":"Necropsy evidence of central cholinergic deficits in senile dementia","volume":"309","author":"Perry","year":"1977","journal-title":"Lancet"},{"issue":"8000","key":"10.1016\/j.cbi.2025.111830_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in ALZHEIMER\u2019S disease","volume":"308","author":"Davies","year":"1976","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","article-title":"The FDA-approved Anti-Amyloid-\u03b2 monoclonal antibodies for the treatment of alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"28","author":"Wu","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"5","key":"10.1016\/j.cbi.2025.111830_bib10","doi-asserted-by":"crossref","first-page":"afae106","DOI":"10.1093\/ageing\/afae106","article-title":"Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study","volume":"53","author":"Reyes","year":"2024","journal-title":"Age Ageing"},{"issue":"7","key":"10.1016\/j.cbi.2025.111830_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A perspective on multi-target drugs for alzheimer's disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.cbi.2025.111830_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tips.2024.05.005","article-title":"Multi-target drugs for alzheimer's disease","volume":"45","author":"Turgutalp","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget\u2010directed ligands approach for the treatment of alzheimer's disease","volume":"33","author":"Le\u00f3n","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2025.111830_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116569","article-title":"New insights into butyrylcholinesterase: pharmaceutical applications, selective inhibitors and multitarget-directed ligands","volume":"275","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111830_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108748","article-title":"Dual inhibition of butyrylcholinesterase and P38\u03b1 mitogen-activated protein kinase: a new approach for the treatment of alzheimer's disease","volume":"264","author":"Ferjan\u010di\u010d Benetik","year":"2024","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.cbi.2025.111830_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","article-title":"Physiological roles for butyrylcholinesterase: a BChE-Ghrelin axis","volume":"259","author":"Brimijoin","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2025.111830_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Therapeut."},{"issue":"10","key":"10.1016\/j.cbi.2025.111830_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2174\/092986609789071207","article-title":"Structure, activities and biomedical applications of human butyrylcholinesterase","volume":"16","author":"Masson","year":"2009","journal-title":"PPL"},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2025.111830_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111552","article-title":"Treatment of acute organophosphate poisoning by using a cocaine hydrolase engineered from human butyrylcholinesterase","volume":"416","author":"LeSaint","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cbi.2025.111830_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","article-title":"Butyrylcholinesterase as a diagnostic and therapeutic target for alzheimer's disease","volume":"13","author":"Darvesh","year":"2016","journal-title":"CAR"},{"key":"10.1016\/j.cbi.2025.111830_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118093","article-title":"A novel butyrylcholinesterase inhibitor induces antidepressant, pro-Cognitive, and anti-anhedonic effects in flinders sensitive line rats: the role of the ghrelin-dopamine Cascade","volume":"187","author":"Olivier","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.62.2.220","article-title":"Re-Engineering butyrylcholinesterase as a cocaine hydrolase","volume":"62","author":"Sun","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abb.2009.12.005","article-title":"Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior","volume":"494","author":"Masson","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"issue":"6150","key":"10.1016\/j.cbi.2025.111830_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cbi.2025.111830_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.cbi.2025.111830_bib29","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.7150\/thno.54589","article-title":"Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for alzheimer disease","volume":"11","author":"Rejc","year":"2021","journal-title":"Theranostics"},{"issue":"47","key":"10.1016\/j.cbi.2025.111830_bib30","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers alzheimer \u03b2-Amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2025.111830_bib31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-Amyloid in an alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","article-title":"Alzheimer's disease drug development pipeline: 2018","volume":"4","author":"Cummings","year":"2018","journal-title":"A D Transl. Res. Clin. Interv."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/0115672050306008240321034006","article-title":"Current progress on central cholinergic receptors as TherapeuticTargets for alzheimer's disease","volume":"21","author":"Nagori","year":"2024","journal-title":"CAR"},{"issue":"8","key":"10.1016\/j.cbi.2025.111830_bib35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jphp.12919","article-title":"Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in alzheimer's disease therapy","volume":"70","author":"Verma","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0006-3495(95)80213-4","article-title":"Alpha-bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability","volume":"68","author":"Castro","year":"1995","journal-title":"Biophys. J."},{"key":"10.1016\/j.cbi.2025.111830_bib37","article-title":"\u03917 nicotinic acetylcholine receptor in memory processing","volume":"ejn","author":"Pastor","year":"2023","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.cbi.2025.111830_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bcp.2015.07.018","article-title":"The multiple roles of the \u03917 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system","volume":"97","author":"Koukouli","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/pharmrev.120.000097","article-title":"Therapeutic targeting of \u03b1 7 nicotinic acetylcholine receptors","volume":"73","author":"Papke","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","article-title":"A cog in cognition: how the \u03917 nicotinic acetylcholine receptor is geared towards improving cognitive deficits","volume":"122","author":"Leiser","year":"2009","journal-title":"Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.apsb.2017.09.001","article-title":"The current agonists and positive allosteric modulators of \u03b1 7 nAChR for CNS indications in clinical trials","volume":"7","author":"Yang","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-008-1281-x","article-title":"Drug discrimination and neurochemical studies in \u03917 null mutant mice: tests for the role of nicotinic \u03917 receptors in dopamine release","volume":"203","author":"Quarta","year":"2009","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cbi.2025.111830_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J. Neurobiol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"Seguela","year":"1993","journal-title":"J. Neurosci."},{"issue":"6347","key":"10.1016\/j.cbi.2025.111830_bib45","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/353846a0","article-title":"Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor","volume":"353","author":"Revah","year":"1991","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02505755","article-title":"Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels","volume":"136","author":"Devillers-Thi\u00e9ry","year":"1993","journal-title":"J. Membr. Biol."},{"issue":"5727","key":"10.1016\/j.cbi.2025.111830_bib47","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.1108595","article-title":"Allosteric mechanisms of signal transduction","volume":"308","author":"Changeux","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41422-021-00509-6","article-title":"Structural basis of human \u03917 nicotinic acetylcholine receptor activation","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.cbi.2025.111830_bib49","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03917 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cbi.2025.111830_bib50","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2024.01.032","article-title":"Structural mechanisms of \u03917 nicotinic receptor allosteric modulation and activation","volume":"187","author":"Burke","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41421-025-00788-y","article-title":"Structural basis for allosteric agonism of human \u03917 nicotinic acetylcholine receptors","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-2836(65)80285-6","article-title":"On the nature of allosteric transitions: a plausible model","volume":"12","author":"Monod","year":"1965","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.cbi.2025.111830_bib53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41582-023-00792-4","article-title":"The role of astrocytic \u03917 nicotinic acetylcholine receptors in alzheimer disease","volume":"19","author":"Fontana","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.expneurol.2004.12.015","article-title":"High selective expression of \u03917 nicotinic receptors on astrocytes in the brains of patients with sporadic alzheimer's disease and patients carrying Swedish APP 670\/671 mutation: a possible association with neuritic plaques","volume":"192","author":"Yu","year":"2005","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.cbi.2025.111830_bib55","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"\u03b2-Amyloid1\u201342 binds to \u03917 nicotinic acetylcholine receptor with high affinity","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"53","key":"10.1016\/j.cbi.2025.111830_bib56","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar Amyloid-\u03b2 positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","article-title":"Intracellular accumulation of \u03b2-Amyloid1\u201342 in neurons is facilitated by the \u03917 nicotinic acetylcholine receptor in alzheimer's disease","volume":"110","author":"Nagele","year":"2002","journal-title":"Neuroscience"},{"issue":"28","key":"10.1016\/j.cbi.2025.111830_bib58","doi-asserted-by":"crossref","first-page":"25056","DOI":"10.1074\/jbc.M200066200","article-title":"\u03b2-Amyloid peptide activates \u03917 nicotinic acetylcholine receptors expressed in xenopus oocytes","volume":"277","author":"Dineley","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib59","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1471-4159.2008.05483.x","article-title":"Role of GSK\u20103\u03b2 activation and \u03917 nAChRs in A\u03b21\u201342 \u2010induced Tau phosphorylation in PC12 cells","volume":"106","author":"Hu","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2025.111830_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.npep.2018.12.003","article-title":"Alpha 7 nicotinic acetylcholine receptor and its effects on alzheimer's disease","volume":"73","author":"Ma","year":"2019","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2008.06.018","article-title":"Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine","volume":"203","author":"Nizri","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12974-021-02149-4","article-title":"Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the \u03917 nicotinic acetylcholine receptor GAT107","volume":"18","author":"Mizrachi","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib64","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","article-title":"Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus","volume":"94","author":"Freedman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cbi.2025.111830_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114010","article-title":"Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor","volume":"177","author":"Cieslikiewicz-Bouet","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"22","key":"10.1016\/j.cbi.2025.111830_bib66","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1021\/jm301048a","article-title":"Discovery of (2 S ,3 R)- N -[2-(Pyridin-3-Ylmethyl)-1-Azabicyclo[2.2.2]Oct-3-Yl]Benzo[ b ]Furan-2-Carboxamide (TC-5619), a selective \u03917 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disorders","volume":"55","author":"Mazurov","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111830_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112282","article-title":"N-Alkylpiperidine carbamates as potential anti-alzheimer\u2019s agents","volume":"197","author":"Ko\u0161ak","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.cbi.2025.111830_bib68","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1021\/acs.jmedchem.5c00577","article-title":"Lead optimization of a butyrylcholinesterase inhibitor for the treatment of alzheimer's disease","volume":"68","author":"Ko\u0161ak","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an In-Vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib70","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1124\/mol.107.033928","article-title":"The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates","volume":"71","author":"Groner","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111830_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115048","article-title":"Pseudo-irreversible butyrylcholinesterase inhibitors: structure\u2013activity relationships, computational and crystallographic study of the N-Dialkyl O-Arylcarbamate warhead","volume":"247","author":"Meden","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.cbi.2025.111830_bib72","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an alzheimer's disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib73","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/pharmaceutics13030420","article-title":"Quinuclidine-based carbamates as potential CNS active compounds","volume":"13","author":"Mato\u0161evi\u0107","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.cbi.2025.111830_bib74","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.bmcl.2005.02.045","article-title":"2-(Arylmethyl)-3-Substituted quinuclidines as selective \u03917 nicotinic receptor ligands","volume":"15","author":"Mazurov","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"19","key":"10.1016\/j.cbi.2025.111830_bib75","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1021\/jm100834y","article-title":"Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptor \u03917 ligands","volume":"53","author":"De Kloe","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111830_bib76","series-title":"NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS. WO 2023\/213740 Al","author":"Hoeng","year":"2023"},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an In-Vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.cbi.2025.111830_bib78","doi-asserted-by":"crossref","first-page":"16276","DOI":"10.1021\/acs.jmedchem.3c01635","article-title":"Optimization of novel \u03917 nicotinic acetylcholine receptor positive allosteric modulators and the discovery of a preclinical development candidate molecule (RGH-560)","volume":"66","author":"Ledneczki","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111830_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113189","article-title":"Discovery of novel positive allosteric modulators of the \u03917 nicotinic acetylcholine receptor: scaffold hopping approach","volume":"214","author":"Ledneczki","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.cbi.2025.111830_bib80","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1523\/JNEUROSCI.5269-04.2005","article-title":"A novel positive allosteric modulator of the \u03917 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization","volume":"25","author":"Hurst","year":"2005","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.cbi.2025.111830_bib81","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.jmedchem.7b01895","article-title":"Dual nicotinic acetylcholine receptor \u03914\u03b22 Antagonists\/\u03917 agonists: synthesis, docking studies, and pharmacological evaluation of tetrahydroisoquinolines and tetrahydroisoquinolinium salts","volume":"61","author":"Crestey","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib82","first-page":"65","article-title":"Preclinical characterization of A\u2010582941: a novel \u03917 neuronal nicotinic receptor agonist with broad spectrum cognition\u2010enhancing properties","volume":"14","author":"Tietje","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.cbi.2025.111830_bib83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2006.04355.x","article-title":"The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery","volume":"101","author":"Papke","year":"2007","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.cbi.2025.111830_bib84","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pro.661","article-title":"Backdoor opening mechanism in acetylcholinesterase based on x\u2010ray crystallography and molecular dynamics simulations","volume":"20","author":"Sanson","year":"2011","journal-title":"Protein Sci."},{"issue":"45","key":"10.1016\/j.cbi.2025.111830_bib85","doi-asserted-by":"crossref","first-page":"27819","DOI":"10.1016\/S0021-9258(18)46859-7","article-title":"The \u201cBack Door\u201d hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis","volume":"269","author":"Kronman","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cbi.2025.111830_bib86","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/molecules25051198","article-title":"A second look at the crystal structures of Drosophila melanogaster acetylcholinesterase in complex with tacrine derivatives provides insights concerning catalytic intermediates and the design of specific insecticides","volume":"25","author":"Nachon","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.cbi.2025.111830_bib87","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.bpj.2010.10.047","article-title":"Long route or shortcut? A molecular dynamics study of traffic of thiocholine within the active-site gorge of acetylcholinesterase","volume":"99","author":"Xu","year":"2010","journal-title":"Biophys. J."},{"issue":"4","key":"10.1016\/j.cbi.2025.111830_bib88","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jnc.15821","article-title":"\u03917 nicotinic receptors play a role in regulation of cardiac hemodynamics","volume":"168","author":"Targosova","year":"2024","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib89","doi-asserted-by":"crossref","first-page":"H526","DOI":"10.1152\/ajpheart.00672.2024","article-title":"Cardiac acetylcholinesterase and butyrylcholinesterase have distinct localization and function","volume":"328","author":"Dingov\u00e1","year":"2025","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib90","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.apsb.2017.09.001","article-title":"The current agonists and positive allosteric modulators of \u03b1 7 nAChR for CNS indications in clinical trials","volume":"7","author":"Yang","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib91","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib92","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.0014-2956.2001.02692.x","article-title":"Engineering of a monomeric and low\u2010glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization","volume":"269","author":"Nachon","year":"2002","journal-title":"Eur. J. Biochem."},{"issue":"47","key":"10.1016\/j.cbi.2025.111830_bib93","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1021\/ja804941z","article-title":"Aging of cholinesterases phosphylated by tabun proceeds through O-Dealkylation","volume":"130","author":"Carletti","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib94","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/aps.2009.54","article-title":"Ric-3 chaperone-mediated stable cell-surface expression of the neuronal \u03917 nicotinic acetylcholine receptor in mammalian cells","volume":"30","author":"Vall\u00e9s","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib95","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cell.2005.07.013","article-title":"Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice","volume":"122","author":"Ding","year":"2005","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.cbi.2025.111830_bib96","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: huprine\u2010based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.cbi.2025.111830_bib97","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1107\/S0909049509036681","article-title":"A framework for plugin-based applications applied to X-Ray experiment online data analysis","volume":"16","author":"Incardona","year":"2009","journal-title":"J. Synchrotron Radiat."},{"issue":"10","key":"10.1016\/j.cbi.2025.111830_bib98","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-Rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"issue":"4","key":"10.1016\/j.cbi.2025.111830_bib99","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/pro.3791","article-title":"Current developments in coot for macromolecular model building of electron cryo\u2010microscopy and crystallographic data","volume":"29","author":"Casa\u00f1al","year":"2020","journal-title":"Protein Sci."},{"issue":"10","key":"10.1016\/j.cbi.2025.111830_bib100","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"12","key":"10.1016\/j.cbi.2025.111830_bib101","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib102","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical p Ka predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"issue":"21","key":"10.1016\/j.cbi.2025.111830_bib103","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2025.111830_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2008.137","article-title":"Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach","volume":"6","author":"Piper","year":"2008","journal-title":"Assay Drug Dev. Technol."},{"issue":"3","key":"10.1016\/j.cbi.2025.111830_bib105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1246\/bcsj.20200369","article-title":"Asymmetric O-to-C aryloxycarbonyl migration of indolyl carbonates using single-handed dynamic helical polyquinoxalines bearing 4-Aminopyridyl groups as chiral nucleophilic catalysts","volume":"94","author":"Yamamoto","year":"2021","journal-title":"Bull. Chem. Soc. Jpn."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725004600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725004600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:52:12Z","timestamp":1766098332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725004600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":101,"alternative-id":["S0009279725004600"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111830","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and \u03b17 nicotinic receptor","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111830"}}